Colgate Q4 Earnings Beat, Revs Lag - Analyst Blog

By
A A A

Colgate-Palmolive Co. ( CL ), a global dealer in consumer goods, reported fourth-quarter 2013 adjusted earnings of 75 cents per share that came a penny ahead of the Zacks Consensus Estimate and rose 7.1% from the year-ago quarter adjusted earnings of 70 cents.

Global sales of $4,361 million increased 2.0% from the prior-year quarter level of $4,286 million, primarily benefiting from a 6.5% rise in global unit volumes, partially offset by a negative impact of 4.5% from foreign exchange rates. However, quarterly revenues fell short of the Zacks Consensus Estimate of $4,391 million.

On an organic basis (excluding foreign exchange, acquisitions and divestitures), the company recorded sales growth of 6.5%.

Adjusted gross profit margin expanded 50 basis points (bps) to 58.9%, driven by better cost containment. This was partially offset by increased raw and packaging material expenses.

Adjusted selling, general and administrative (SG&A) expenses, as a percentage of revenues, grew 10 bps from the year-ago quarter to 34.5%.  The rise was mainly due to higher advertising investment and lower overhead costs, both as a percentage of sales.

In the quarter, adjusted operating profit of $1,074 million increased 4% from $1,035 million from the year-ago period. Consequently, operating margin improved 50 bps to 24.6%.

In 2013, Colgate-Palmolive's market share of global toothpaste and manual toothbrushes reached 44.9% and 32.8%, respectively. Additionally, the company's mouthwash business has made significant progress, with its global market share reaching a record of 17% in the year, a 130-bp improvement from 2012.

Segment Discussion

North America sales (18% of total sales) rose 2.5% in the quarter, driven by a 4% rise in unit volume and flat pricing, partly offset by a negative impact of 1% and 0.5% from lower pricing and foreign exchange, respectively. On an organic basis, sales increased 3%.

Segment operating profit increased 5% to $241 million, while operating margin expanded nearly 70 bps to 31.2%. The year-over-year rise in operating profit margin was chiefly driven by increased gross profit margin, which was partially offset by higher SG&A expenses as a percentage of net sales.

Latin America sales (29% of total sales) inched up 1% year over year, primarily driven by a 10% increase in pricing and 2.5% unit volume growth, partially offset by a negative foreign exchange impact of 11.5%. Volume gains were most prominent in Venezuela, Brazil, Mexico and Colombia. On an organic basis, sales increased 12.5%.

Operating profit increased 3% to $363 million while as a percentage of sales, it improved 50 bps to 28.7% primarily due to lower SG&A expenses as a percentage of sales, which was partially offset by decline in gross profit margin.

Europe/South Pacific sales (19% of total sales) dipped 0.5% year over year, as the benefit of 2.5% rise in unit volume and 1.5% positive impact from foreign exchange were more than offset by a 4.5% downside in pricing. Volume gains were primarily led by the United Kingdom, Australia and Poland. Organic sales for the region were down 1.5%.

However, operating profit increased 7% year over year to $200 million. Furthermore, the operating profit margin in the region expanded 160 bps to 23.7% attributable to higher gross profit margin, which was partially offset by increased SG&A expenses as a percentage of sales.

Asia sales (14% of total sales) climbed 4.5%, with a 10.5% increase in unit volume, offset by a 4.5% negative impact from foreign currency and 1.5% lower pricing. Volume growth was primarily led by gains in India, the Greater China region and the Philippines. On an organic basis, sales grew 9%.

Operating profit rose 14% to $165 million. Operating margin expanded 230 basis points to 28.8%, on account of improved gross margin and lower SG&A expenses as a percentage of sales.

Africa/Eurasia sales (7% of total sales) inched up 0.5% year over year, driven by 6% growth in unit volume and 1% increase in prices, offset by a 6.5% negative impact from foreign currency exchange. Volume gains were primarily led by Russia, the Sub-Saharan Africa region, Turkey and the Central Asia/Caucasus region. Organic sales for the region rose 7%.

Operating profit increased 9% year over year to $76 million, while operating margin expanded 170 basis points to 23.4%. The increase was driven by higher gross profit margin and decrease in SG&A expenses as a percentage of sales.

Hill's Pet Nutrition sales (13% of total sales) grew 4.5%. Unit volume increased 4% due to volume gains in U.S., Russia and Canada, partly offset by volume declines in Japan. Pricing had a 3% positive impact on sales growth, while foreign exchange negatively impacted sales by 2.5%. On an organic basis, sales rose 7% from the year-ago quarter.

Operating profit improved 3% to $153 million, whereas operating profit margin contracted 50 bps to 26.2%. The decline in operating margin was due to lower gross profit margin, partially offset by reduced SG&A expenses as a percentage of net sales.

Full-Year Synopsis

For 2013, the company's adjusted earnings came at $2.84 per share, up 6% from 2012 and surpassed the Zacks Consensus Estimate by a penny. Revenues for the year rose approximately 2% to $17,420 million. However, the company's top line missed the Zacks Consensus Estimate of $17,451 million.

Other Financial Details

Colgate-Palmolive, which competes with The Procter & Gamble Co. ( PG ), ended the fiscal with cash and cash equivalents of $962 million, total debt of $5,657 million and shareholders' equity of $2,305 million. Net cash provided by operating activities came in at $3,204 million for the period.

Guidance

Looking ahead, Colgate-Palmolive anticipates its growth momentum to continue into 2014 as it remains on track with its global restructuring program. Further, the company's stringent focus on funding-the-growth programs and strategic worldwide pricing endeavors should help boost its bottom line. As a result, the company expects strong earnings well as gross margin expansion in 2014.

Other Stocks to Consider

Currently, Colgate-Palmolive carries a Zacks Rank #4 (Sale). However, some better-ranked stocks in the consumer staples sector that are worth considering include Chemtura Corp. ( CHMT ) and Sensient Technologies Corp. ( SXT ). All these stocks carry a Zacks Rank #2 (Buy).



CHEMTURA CORP (CHMT): Free Stock Analysis Report

COLGATE PALMOLI (CL): Free Stock Analysis Report

PROCTER & GAMBL (PG): Free Stock Analysis Report

SENSIENT TECH (SXT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Earnings , Stocks

Referenced Stocks: CHMT , CL , PG , SXT

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

55,414,702
  • $15.38 ▼ 0.39%
38,503,210
  • $66.34 ▲ 2.26%
36,466,704
  • $8.36 ▼ 9.52%
35,253,294
  • $26.55 ▲ 1.34%
32,752,347
  • $6.55 ▲ 1.87%
31,778,001
  • $95.22 ▲ 0.19%
28,396,556
  • $51.49 ▼ 0.62%
23,800,987
  • $42.09 ▲ 0.97%
As of 7/11/2014, 04:03 PM